Skip to main content

Table 3. Multivariate analysis for relapse incidence after haplo-SCT for ALL and AML

From: Leukemia relapse following unmanipulated haploidentical transplantation: a risk factor analysis on behalf of the ALWP of the EBMT

  1. ALL acute lymphoblastic leukemia, AML acute myeloid leukemia, RI relapse incidence, HR hazard ratio, SCT stem cell transplant, CR complete remission, HCT-CI hematopoietic cell transplantation comorbidity index, CMV cytomegalovirus
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us